NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
30.77
+0.91 (3.05%)
Mar 9, 2026, 4:00 PM EDT - Market closed
NAMS Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 490 | 771.74 | 340.45 | 467.73 | 60.38 | Upgrade
|
| Short-Term Investments | 146.24 | 62.45 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 636.24 | 834.19 | 340.45 | 467.73 | 60.38 | Upgrade
|
| Cash Growth | -23.73% | 145.03% | -27.21% | 674.64% | 527.92% | Upgrade
|
| Other Receivables | 23.15 | 21.31 | 1.88 | 2.07 | 4.88 | Upgrade
|
| Receivables | 23.15 | 21.31 | 1.88 | 2.07 | 4.88 | Upgrade
|
| Prepaid Expenses | 14.99 | 7.92 | 4.46 | 8.18 | 1.7 | Upgrade
|
| Restricted Cash | 1.32 | - | - | - | - | Upgrade
|
| Total Current Assets | 675.7 | 863.41 | 346.79 | 477.98 | 66.96 | Upgrade
|
| Property, Plant & Equipment | 0.57 | 0.67 | 0.1 | 0.15 | 0.22 | Upgrade
|
| Long-Term Investments | 92.61 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 0.41 | 0.53 | 0.17 | 0.21 | - | Upgrade
|
| Other Long-Term Assets | - | - | 0.04 | 0.16 | - | Upgrade
|
| Total Assets | 769.28 | 864.62 | 347.1 | 478.5 | 67.99 | Upgrade
|
| Accounts Payable | 8.97 | 4.74 | 16.92 | 11.85 | 7.07 | Upgrade
|
| Accrued Expenses | 15.42 | 13.61 | 11.4 | 6.12 | 4.1 | Upgrade
|
| Current Portion of Leases | 0.14 | 0.25 | 0.06 | 0.07 | 0.06 | Upgrade
|
| Current Unearned Revenue | 3.99 | 6.01 | 8.94 | 13.87 | - | Upgrade
|
| Other Current Liabilities | 57.27 | 82.31 | 12.57 | 4.15 | - | Upgrade
|
| Total Current Liabilities | 85.79 | 106.92 | 49.9 | 36.06 | 11.24 | Upgrade
|
| Long-Term Leases | 0.07 | 0.2 | - | 0.06 | 0.13 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 1.02 | 4.79 | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 7.79 | 7.52 | - | Upgrade
|
| Total Liabilities | 85.85 | 107.12 | 58.7 | 48.43 | 11.36 | Upgrade
|
| Common Stock | 14.28 | 13.44 | 10.17 | 10.06 | 0.13 | Upgrade
|
| Additional Paid-In Capital | 1,427 | 1,298 | 590.77 | 555.63 | 95.26 | Upgrade
|
| Retained Earnings | -762.39 | -558.57 | -316.97 | -140.04 | -39.44 | Upgrade
|
| Comprehensive Income & Other | 4.79 | 4.47 | 4.42 | 4.42 | 0.67 | Upgrade
|
| Shareholders' Equity | 683.43 | 757.5 | 288.39 | 430.07 | 56.63 | Upgrade
|
| Total Liabilities & Equity | 769.28 | 864.62 | 347.1 | 478.5 | 67.99 | Upgrade
|
| Total Debt | 0.2 | 0.45 | 0.06 | 0.13 | 0.19 | Upgrade
|
| Net Cash (Debt) | 728.65 | 833.74 | 340.39 | 467.6 | 60.19 | Upgrade
|
| Net Cash Growth | -12.61% | 144.94% | -27.21% | 676.83% | - | Upgrade
|
| Net Cash Per Share | 6.15 | 8.84 | 4.14 | 24.65 | 5.48 | Upgrade
|
| Filing Date Shares Outstanding | 114.98 | 109.82 | 89.27 | 81.77 | 11.33 | Upgrade
|
| Total Common Shares Outstanding | 114.4 | 108.06 | 82.47 | 81.56 | 11.33 | Upgrade
|
| Working Capital | 589.91 | 756.5 | 296.89 | 441.92 | 55.72 | Upgrade
|
| Book Value Per Share | 5.97 | 7.01 | 3.50 | 5.27 | 5.00 | Upgrade
|
| Tangible Book Value | 683.02 | 756.97 | 288.22 | 429.86 | 56.63 | Upgrade
|
| Tangible Book Value Per Share | 5.97 | 7.00 | 3.49 | 5.27 | 5.00 | Upgrade
|
| Machinery | - | - | - | - | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.